RecruitingPhase 2Phase 3NCT06454357

A Clinical Study of B007 in the Treatment of Pemphigus.

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 in Subjects With Pemphigus.

Sponsor

Shanghai Jiaolian Drug Research and Development Co., Ltd

Enrollment

132 participants

Start Date

Jul 12, 2024

Study Type

INTERVENTIONAL

Conditions

Pemphigus

Summary

The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with pemphigus.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called B007 for people with pemphigus. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGB007

B007：high dose/low dose: Subcutaneous injection was administered on days 1 and 15

Locations(12)

Peking University First Hospital

Beijing, China

The Second Xiangya Hospital of Central South University

Changsha, China

Chengdu Second People's Hospital

Chengdu, China

West China Hospital, Sichuan University

Chengdu, China

The First Affiliated Hospital of Chongqing Medical University

Chongqing, China

The First Affiliated Hospital of Fujian Medical University

Fuzhou, China

Dermatology Hospital of Southern Medical University

Guangzhou, China

Guangdong Provincial People's Hospital

Guangzhou, China

Shandong First Medical University-Affiliated Skin Hospital

Jinan, China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, China

Henan Provincial People's Hospital

Zhengzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06454357

Related Trials

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

NCT0589830834 locations

FARD (RaDiCo Cohort) (RaDiCo-FARD)

NCT0595441615 locations

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

NCT0669671625 locations

A Two-Part Study to Assess the Effects of Ritonavir on PRN1008 Pharmacokinetics, and the Effect of PRN1008 on QTc Interval Compared to Placebo and Moxifloxacin in Healthy Participants

ACTRN126180010362021 location